Navamedic ASA is a Norwegian medtech and pharmaceutical products company, marketing products to patients, hospitals and pharmacies in the Nordic, Benelux and Baltic markets.
The Group's Medtech business has developed and is currently introducing the next generation of digital urine meter Sippi®. Navamedic is listed on the Oslo Stock Exchange.
The product portfolio includes original and generic pharmaceuticals as well as food supplements, medical devices and other health care products. Navamedic's Pharma and Healthcare business is a distributor of products supplied by a number of pharmaceutical manufacturers.
Navamedic, established in 2002, consists of Navamedic ASA and the 100% owned subsidiaries Navamedic AB, Navamedic AS and Observe Medical International AB. Navamedic has its headoffice in Lysaker, Oslo. Navamedic has been listed on Oslo Stock Exchange since 2006.
Navamedic AB (earlier Vitaflo Scandinavia AB) was established in 1999 and became a part of the Navamedic group in 2007. Navamedic AB focuses on inlicensing and buying pharmaceuticals and other healthcare products within a few selected knowledge areas. Navamedic AB has sales and distribution in Norway, Sweden, Denmark, Finland and the Netherlands as well as some additional export markets.